Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Upstream Biosciences has entered into collaboration with the Provincial Laboratory for Public Health in Alberta, Canada to begin in vitro testing of Upstream's novel compounds for the potential treatment of malaria.
Subscribe to our email newsletter
Upstream’s library of novel compounds has demonstrated encouraging potential in vitro against the tropical parasitic diseases leishmaniasis and trypanosomiasis, and may also have therapeutic utility against the parasite that causes malaria.
Joel Bellenson, CEO of Upstream, said: “We look forward to moving quickly to complete these initial studies so that we can hopefully progress to further preclinical and clinical studies of the candidates that demonstrate the most promise for the treatment of malaria.”